The most common side effects of GLP-1 medications nausea, vomiting, and diarrhoea are well known, but what patients are often not told is how to manage them proactively
Skin quality changes including improved firmness and texture develop more gradually and are usually noticeable by month three
FDA inspections have identified violations including improper equipment use, inadequate supplier vetting, and labeling issues
Stick to the recommended schedule and dosage to maintain stability
ArGLP-1 con indicacin para obesidad Como se ha adelantado, existen dos arGLP-1 indicados para el tratamiento de la obesidad en la UE, en sujetos con IMC 30 kg/m2, o con IMC 27 kg/m2, y al menos una comorbilidad relacionada con el peso, siempre en combinacin con una dieta apropiada y ejercicio fsico: liraglutida 3 mg y semaglutida 2,4 mg